The Colorectal Cancer Market size in the Middle East & Africa was worth USD 1.70 billion in 2022. This value is estimated to be growing at a CAGR of 2.07% to reach USD 1.89 billion by 2027.
An estimated 5000 people from Saudi Arabia are diagnosing with Cancer every year. Growing health awareness and increasing medical tourism in emerging countries are some of the key factors driving the market in this region.
The surgery treatment associated with colorectal cancer is so expensive. It is not affordable by many of the patients is one of the key factors hampering the market in this region.
This research report on the MEA Colorectal Cancer Market has been segmented and sub-segmented into the following categories:
Regionally, UAE is considered to lead the colorectal cancer of the MEA region, followed by Saudi Arabia. Other significant markets in this region include Zimbabwe, Zambia, Tanzania, and Nigeria. The market in this region has the lowest share due to the general lack of awareness.
Key market players in MEA Colorectal Cancer Market profiled in this report are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, and Vaccinogen BD.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com